NDC 50242-132
Herceptin 150 mg per 7.4 mL injection, powder, lyophilized, for solution
On the label: Genentech, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Genentech, Inc. | South San Francisco, CA, United States | Makes it and tests it | No problems foundMay 15, 2026 · 37 inspections |
| Genentech, Inc. | Hillsboro, OR, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyApr 19, 2024 · 7 inspections |
| Roche Diagnostics GmbH | Penzberg, Germany | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMay 22, 2025 · 6 inspections |
| Roche Singapore Technical Operations Pte. Ltd. | Singapore, Singapore | Makes the active ingredient and tests it | Problems found, fixed voluntarilyNov 14, 2025 · 6 inspections |
| Genentech, Inc. | Oceanside, CA, United States | Tests it | No problems foundAug 16, 2024 · 5 inspections |
| Roche Diagnostics GmbH | Mannheim, Germany | Tests it | Problems found, fixed voluntarilyOct 29, 2021 · 5 inspections |
Product details
- Generic drug
- Trastuzumab: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous
- Strength
- 150 mg per 7.4 mL
- Approval
- BLA BLA103792
- On the market since
- Feb 10, 2017
- Package NDCs
50242-132-01- Official label
- DailyMed (National Library of Medicine), updated May 29, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?